跳至主要内容
临床试验/ACTRN12618002044202
ACTRN12618002044202招募中未知

A multi-centre, pilot randomised controlled trial of a post-acute kidney injury care bundle in patients at high risk of major adverse kidney events

Austin Health0 个研究点目标入组 200 人开始时间: 2018年12月20日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
Austin Health
入组人数
200

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • ALL of the following:
  • 1. Adult patients admitted to ICU or CCU
  • 2. Kidney Disease Improving Global Outcomes (KDIGO) stage 2 or 3 AKI
  • 3. Alive and independent of RRT for 72 hours at discharge with no plan for RRT following discharge from hospital
  • 4. Written informed consent

排除标准

  • ANY of the following:
  • 1. Age less than 18 years
  • 2. Life expectancy <90 days
  • 3. Baseline eGFR <30mL/min/1.73m2 (or no eGFR within 12 months)
  • 4. Kidney transplant recipient
  • 5. AKI due to suspected or proven glomerulonephritis, vasculitis, tubulointerstitial nephritis, thrombotic microangiopathy, pregnancy, myeloma, or hepatorenal syndrome
  • 6. Previously enrolled in this study
  • 7. Previously reviewed by a nephrologist within the preceding 12 months with the intention of ongoing follow-up

研究者

发起方
Austin Health

相似试验